Cargando…
Plasmablastic lymphoma in Malawi
Plasmablastic lymphoma (PBL) clinical descriptions are scarce from sub-Saharan Africa (SSA) where both HIV and EBV are highly endemic. We identified 12 patients with pathologically confirmed PBL from a prospective cohort in Lilongwe, Malawi. Median age was 46 (range 26–71), seven (58%) were male, an...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022505/ https://www.ncbi.nlm.nih.gov/pubmed/29988350 http://dx.doi.org/10.1186/s13027-018-0195-4 |
_version_ | 1783335692148932608 |
---|---|
author | Zuze, Takondwa Painschab, Matthew S. Seguin, Ryan Kudowa, Evarista Kaimila, Bongani Kasonkanji, Edwards Tomoka, Tamiwe Dhungel, Bal Mukunda Mulenga, Maurice Chikasema, Maria Tewete, Blessings Ntangwanika, Asekanadziwa Chiyoyola, Sarah Chimzimu, Fred Kampani, Coxcilly Krysiak, Robert Montgomery, Nathan D. Fedoriw, Yuri Gopal, Satish |
author_facet | Zuze, Takondwa Painschab, Matthew S. Seguin, Ryan Kudowa, Evarista Kaimila, Bongani Kasonkanji, Edwards Tomoka, Tamiwe Dhungel, Bal Mukunda Mulenga, Maurice Chikasema, Maria Tewete, Blessings Ntangwanika, Asekanadziwa Chiyoyola, Sarah Chimzimu, Fred Kampani, Coxcilly Krysiak, Robert Montgomery, Nathan D. Fedoriw, Yuri Gopal, Satish |
author_sort | Zuze, Takondwa |
collection | PubMed |
description | Plasmablastic lymphoma (PBL) clinical descriptions are scarce from sub-Saharan Africa (SSA) where both HIV and EBV are highly endemic. We identified 12 patients with pathologically confirmed PBL from a prospective cohort in Lilongwe, Malawi. Median age was 46 (range 26–71), seven (58%) were male, and six (50%) were HIV-positive. Eight patients were treated with CHOP and four with a modified EPOCH regimen. One-year overall survival was 56% (95% CI 24–79%), without clear differences based on HIV status. PBL occurs in Malawi in HIV-positive and HIV-negative individuals and can be treated successfully with curative intent, even in a low-resource setting in SSA. |
format | Online Article Text |
id | pubmed-6022505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60225052018-07-09 Plasmablastic lymphoma in Malawi Zuze, Takondwa Painschab, Matthew S. Seguin, Ryan Kudowa, Evarista Kaimila, Bongani Kasonkanji, Edwards Tomoka, Tamiwe Dhungel, Bal Mukunda Mulenga, Maurice Chikasema, Maria Tewete, Blessings Ntangwanika, Asekanadziwa Chiyoyola, Sarah Chimzimu, Fred Kampani, Coxcilly Krysiak, Robert Montgomery, Nathan D. Fedoriw, Yuri Gopal, Satish Infect Agent Cancer Short Report Plasmablastic lymphoma (PBL) clinical descriptions are scarce from sub-Saharan Africa (SSA) where both HIV and EBV are highly endemic. We identified 12 patients with pathologically confirmed PBL from a prospective cohort in Lilongwe, Malawi. Median age was 46 (range 26–71), seven (58%) were male, and six (50%) were HIV-positive. Eight patients were treated with CHOP and four with a modified EPOCH regimen. One-year overall survival was 56% (95% CI 24–79%), without clear differences based on HIV status. PBL occurs in Malawi in HIV-positive and HIV-negative individuals and can be treated successfully with curative intent, even in a low-resource setting in SSA. BioMed Central 2018-06-28 /pmc/articles/PMC6022505/ /pubmed/29988350 http://dx.doi.org/10.1186/s13027-018-0195-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Zuze, Takondwa Painschab, Matthew S. Seguin, Ryan Kudowa, Evarista Kaimila, Bongani Kasonkanji, Edwards Tomoka, Tamiwe Dhungel, Bal Mukunda Mulenga, Maurice Chikasema, Maria Tewete, Blessings Ntangwanika, Asekanadziwa Chiyoyola, Sarah Chimzimu, Fred Kampani, Coxcilly Krysiak, Robert Montgomery, Nathan D. Fedoriw, Yuri Gopal, Satish Plasmablastic lymphoma in Malawi |
title | Plasmablastic lymphoma in Malawi |
title_full | Plasmablastic lymphoma in Malawi |
title_fullStr | Plasmablastic lymphoma in Malawi |
title_full_unstemmed | Plasmablastic lymphoma in Malawi |
title_short | Plasmablastic lymphoma in Malawi |
title_sort | plasmablastic lymphoma in malawi |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022505/ https://www.ncbi.nlm.nih.gov/pubmed/29988350 http://dx.doi.org/10.1186/s13027-018-0195-4 |
work_keys_str_mv | AT zuzetakondwa plasmablasticlymphomainmalawi AT painschabmatthews plasmablasticlymphomainmalawi AT seguinryan plasmablasticlymphomainmalawi AT kudowaevarista plasmablasticlymphomainmalawi AT kaimilabongani plasmablasticlymphomainmalawi AT kasonkanjiedwards plasmablasticlymphomainmalawi AT tomokatamiwe plasmablasticlymphomainmalawi AT dhungelbalmukunda plasmablasticlymphomainmalawi AT mulengamaurice plasmablasticlymphomainmalawi AT chikasemamaria plasmablasticlymphomainmalawi AT teweteblessings plasmablasticlymphomainmalawi AT ntangwanikaasekanadziwa plasmablasticlymphomainmalawi AT chiyoyolasarah plasmablasticlymphomainmalawi AT chimzimufred plasmablasticlymphomainmalawi AT kampanicoxcilly plasmablasticlymphomainmalawi AT krysiakrobert plasmablasticlymphomainmalawi AT montgomerynathand plasmablasticlymphomainmalawi AT fedoriwyuri plasmablasticlymphomainmalawi AT gopalsatish plasmablasticlymphomainmalawi |